Search Results

Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials initiative.

• Authors : Wyse RK; Cure Parkinson's, London, UK.; Isaacs T

• Source: Journal of Parkinson's disease [J Parkinsons Dis] 2024 Apr 05. Date of Electronic Publication: 2024 Apr 05.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101567362 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Transient exposure to rotenone causes degeneration and progressive parkinsonian motor deficits, neuroinflammation, and synucleinopathy.

• Authors : Van Laar AD; Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA.

• Source: NPJ Parkinson's disease [NPJ Parkinsons Dis] 2023 Aug 11; Vol. 9 (1), pp. 121. Date of Electronic Publication: 2023 Aug 11.Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101675390 Publication Model: Electronic Cited Medium: Print ISSN:

Record details

The Water, the Air, the Marines-Camp Lejeune, Trichloroethylene, and Parkinson Disease.

• Authors : Dorsey ER; Center for Health + Technology and Department of Neurology, University of Rochester Medical Center, Rochester, New York.; Greenamyre JT

Subjects: Military Personnel* ; Trichloroethylene*/Trichloroethylene*/Trichloroethylene*/toxicity ; Parkinson Disease*

• Source: JAMA neurology [JAMA Neurol] 2023 Jul 01; Vol. 80 (7), pp. 663-665.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589536 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Neuroprotective actions of a fatty acid nitroalkene in Parkinson's disease.

• Authors : Di Maio R; Pittsburgh Institute for Neurodegenerative Diseases, Pittsburgh, PA, 15213, USA. .; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, 15213, USA. .

• Source: NPJ Parkinson's disease [NPJ Parkinsons Dis] 2023 Apr 07; Vol. 9 (1), pp. 55. Date of Electronic Publication: 2023 Apr 07.Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101675390 Publication Model: Electronic Cited Medium: Print ISSN:

Record details

NADPH oxidase 2 activity in Parkinson's disease.

• Authors : Keeney MT; Pittsburgh Institute for Neurodegenerative Diseases, Pittsburgh, PA 15213, USA; Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213, USA

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/metabolism ; alpha-Synuclein*/alpha-Synuclein*/alpha-Synuclein*/metabolism; Animals

• Source: Neurobiology of disease [Neurobiol Dis] 2022 Aug; Vol. 170, pp. 105754. Date of Electronic Publication: 2022 May 13.Publisher: Academic Press Country of Publication: United States NLM ID: 9500169 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability.

• Authors : Hallacli E; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Division of Movement Disorders, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/metabolism ; alpha-Synuclein*/alpha-Synuclein*/alpha-Synuclein*/genetics ; alpha-Synuclein*/alpha-Synuclein*/alpha-Synuclein*/metabolism

• Source: Cell [Cell] 2022 Jun 09; Vol. 185 (12), pp. 2035-2056.e33.Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print Cited Medium: Internet ISSN: 1097-4172

Record details

LRRK2 and idiopathic Parkinson's disease.

• Authors : Rocha EM; Pittsburgh Institute for Neurodegenerative Diseases and Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Keeney MT

Subjects: Parkinson Disease*; Endosomes/Endosomes/Endosomes/metabolism ; Humans

• Source: Trends in neurosciences [Trends Neurosci] 2022 Mar; Vol. 45 (3), pp. 224-236. Date of Electronic Publication: 2022 Jan 04.Publisher: Elsevier Applied Science Publishing Country of Publication: England NLM ID: 7808616 Publication Model: Print-Electronic Cited Medium:

Record details

Preventing Parkinson's Disease: An Environmental Agenda.

• Authors : De Miranda BR; Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA.; Goldman SM

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/etiology ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/prevention & control ; Pesticides*

• Source: Journal of Parkinson's disease [J Parkinsons Dis] 2022; Vol. 12 (1), pp. 45-68.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101567362 Publication Model: Print Cited Medium: Internet ISSN: 1877-718X

Record details

VGLUT2 Is a Determinant of Dopamine Neuron Resilience in a Rotenone Model of Dopamine Neurodegeneration.

• Authors : Buck SA; Center for Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania, 15213.; Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, 15213.

Subjects: Dopaminergic Neurons/Dopaminergic Neurons/Dopaminergic Neurons/*pathology ; Nerve Degeneration/Nerve Degeneration/Nerve Degeneration/*pathology ; Parkinsonian Disorders/Parkinsonian Disorders/Parkinsonian Disorders/*metabolism

• Source: The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2021 Jun 02; Vol. 41 (22), pp. 4937-4947. Date of Electronic Publication: 2021 Apr Publisher: Society for Neuroscience Country of Publication: United States NLM ID: 8102140 Publication Model: Print-Electronic Cited Medium: Internet

Record details

The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's disease.

• Authors : De Miranda BR; Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, Department of Neurology, University of Pittsburgh, Pittsburgh, PA, United States of America. Electronic address: .; Castro SL

Subjects: Dopaminergic Neurons/Dopaminergic Neurons/Dopaminergic Neurons/*drug effects ; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2/Leucine-Rich Repeat Serine-Threonine Protein Kinase-2/Leucine-Rich Repeat Serine-Threonine Protein Kinase-2/*drug effects ; Neostriatum/Neostriatum/Neostriatum/*drug effects

• Source: Neurobiology of disease [Neurobiol Dis] 2021 Jun; Vol. 153, pp. 105312. Date of Electronic Publication: 2021 Feb 23.Publisher: Academic Press Country of Publication: United States NLM ID: 9500169 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details